Patent 42

A method for preparing Janus paper by mycelia and Janus paper. The method includes the steps of: step 1, inactivation of mycelia; step 2, fibrillation of mycelia; step 3, purification of solid-state fermented mycelia; step 4, gelation of secondary fermented mycelia; and step 5, preparation of Janus paper. In the present disclosure, Janus paper is prepared using edible fungus mycelia, which can replace the traditional papermaking method that uses wood as a main raw material. No plastics or chemical coatings need to be added, and this disclosure has the advantages of environmental protection, low carbon emissions, and biodegradability.

The present invention belongs to the technical field of medical devices, and in particular, relates to a vaginal function exerciser, including: an inserting end, an irrigating pipeline being arranged at a front end of the inserting end, and an expansion unit being arranged at a middle part of the inserting end; and a host, a first port of the host communicating with the expansion unit through a second hose, a second port of the host communicating with the irrigating pipeline through a first hose. A camera is arranged at the front end of the inserting end, and the camera is electrically connected to a third port of the host through a power supply and signal line. The vaginal function exerciser achieves multiple functions of vaginal exercise and irrigation, so that a patient can perform vaginal irrigation, drug administration and dilation under the guidance of a doctor.

The present application discloses a high zirconia brick and a preparation process and use thereof. The high zirconia brick can include the following components in percentage by weight: 40-99% of zirconia, 0.1-60% of alumina, and 0.1-40% of yttria, iron oxide, titania, magnesia, calcia, and silica in total. In the present application, heating and annealing cooling are controlled by means of curved temperature control, and a high zirconia brick prepared has uniform and segregation-free distribution of all elements and consistent overall density, without defects such as needle-like pores, bubble retention, and surface cavities. The high zirconia brick prepared by the technological method has features of short delivery cycles of products and customizable production

Provided is a mobile phone case (26) with a white printing area and a printing device for same, including a mobile phone case and a workbench (1). A top of the mobile phone case is fixedly connected to a spraying panel (27). An inner wall of the workbench (1) is fixedly connected to a placement table, the placement table provides a placement area for the mobile phone case, a shielding assembly (13) is arranged inside the workbench (1), a top of the workbench is fixedly connected to a raw material box (2), the raw material box (2) is internally fixedly connected to a conveying tube (4), a triple-nozzle tube (16) is arranged at a bottom of the conveying tube (4), and an outer wall of the triple-nozzle tube is provided with a replacement assembly. Protective covers (13) on both sides limit and isolate a spraying range of an outer wall of the mobile phone case.

The disclosure belongs to the technical field of medicine. Provided are a CD97 and GSDME interaction inhibitor having anti-tumor activity and an application thereof. A compound screened in the disclosure enhances the susceptibility of NK cells to kill tumor cells by inhibiting the interaction between GSDME and CD97 in tumor cells, so as to induce an immune anti-tumor effect. Moreover, the compound enhances the susceptibility of tumor cells to pyroptosis by blocking the protective effect of CD97 on cleavage of GSDME proteins. Therefore, the compound can be used for treating GSDME and CD97 double-positive malignant tumors, and combined chemotherapy, immunotherapy, etc., to enhance the susceptibility of malignant tumors to chemotherapy and immunotherapy, prolonging the overall survival period of patients with malignant tumors. Specifically provided is a compound having a structure set forth in formula (I), a pharmaceutically acceptable salt, a solvent compound or a deuterated compound thereof.

Zusammenfassung wird geladen …

Zusammenfassung wird geladen …

Zusammenfassung wird geladen …

Zusammenfassung wird geladen …

Zusammenfassung wird geladen …